US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist
  • 1.6900
  • -0.0300-1.74%
Trading Sep 16 13:16 ET
18.17MMarket Cap-630P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NRX Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.69
-0.75
-0.06
Miss Est.
--
+38.02%
-7.93%
Analyst Rating
Buy

Sep 6, 2024

NRX Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 28, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 28, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

NRX Pharmaceuticals Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 14 16:44 ET

  • 10-Q: Q1 2024 Earnings Report

    May 14 16:36 ET

  • 10-K/A: Annual report (Amendment)

    Apr 29 16:52 ET

  • NRX Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 29 17:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 6, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data